IBOV 166,376.43 ▼ 0.69% COLCAP 2,452.46 — — IPC MEX 68,629.46 ▼ 0.12% MERVAL 2,848,945 — — USD/BRL5.91▼ 0.70% USD/MXN19.14▲ 0.30% USD/CLP 1,022 — 0.00% USD/COP3,483▲ 3.77% USD/PEN3.45▲ 0.19% USD/ARS1,580▲ 0.93% USD/UYU40.61▲ 3.16% USD/PYG6,212▲ 2.34% USD/BOB11.64▲ 2.55% USD/DOP59.52▼ 0.80% USD/CRC441.73▲ 2.68% USD/GTQ7.64▲ 3.22% USD/HNL26.89▲ 3.31% USD/NIO 36.62 — 0.00% USD/VES913.46▼ 0.45% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.59▲ 2.60% USD/TTD6.70▲ 2.00% EUR/BRL6.52▲ 1.12% BRENT 89.95 ▼ 2.21% WTI 83.41 ▲ 0.24% IRON ORE 161.91 — — COPPER 5.49 ▼ 2.49% GOLD 3,515 ▼ 4.62% SILVER 41.07 ▼ 7.33% SOY 1,221 ▲ 1.10% CORN 448.75 ▲ 2.22% WHEAT 592.00 ▲ 2.38% COFFEE 273.35 ▼ 3.08% SUGAR 17.07 ▼ 0.52% ORANGE JUICE 129.25 ▼ 2.49% COTTON 79.30 ▲ 4.41% COCOA 5,150 ▲ 1.72% BEEF 227.70 ▲ 2.18% CATTLE 335.43 ▼ 0.78% LITHIUM 51.98 ▼ 4.33% PETR4 42.67 — 0.00% VALE3 58.48 — 0.00% ITUB4 40.07 — 0.00% BBDC4 13.83 — 0.00% ABEV3 16.08 — 0.00% BBAS3 14.30 — 0.00% B3SA3 14.28 — 0.00% WEGE3 51.13 — 0.00% PRIO3 60.20 — 0.00% SUZB3 55.32 — 0.00% RENT3 28.86 — 0.00% AZZA3 14.63 — 0.00% CSAN3 3.08 — 0.00% RAIZ4 15.00 ▼ 10.71% PCAR3 3.23 — 0.00% GMAT3 4.18 ▲ 3.21% PSSA3 43.96 — 0.00% CVCB3 0.72 ▼ 7.69% POSI3 3.37 ▲ 6.31% SLCE3 17.53 — 0.00% NATU3 4.48 — 0.00% BRKM5 2.60 — 0.00% RANI3 8.01 ▼ 0.74% IBOV 166,376.43 ▼ 0.69% COLCAP 2,452.46 — — IPC MEX 68,629.46 ▼ 0.12% MERVAL 2,848,945 — — USD/BRL 5.91 ▼ 0.70% USD/MXN 19.14 ▲ 0.30% USD/CLP 1,022 — 0.00% USD/COP 3,483 ▲ 3.77% USD/PEN 3.45 ▲ 0.19% USD/ARS 1,580 ▲ 0.93% USD/UYU 40.61 ▲ 3.16% USD/PYG 6,212 ▲ 2.34% USD/BOB 11.64 ▲ 2.55% USD/DOP 59.52 ▼ 0.80% USD/CRC 441.73 ▲ 2.68% USD/GTQ 7.64 ▲ 3.22% USD/HNL 26.89 ▲ 3.31% USD/NIO 36.62 — 0.00% USD/VES 913.46 ▼ 0.45% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.59 ▲ 2.60% USD/TTD 6.70 ▲ 2.00% EUR/BRL 6.52 ▲ 1.12% BRENT 89.95 ▼ 2.21% WTI 83.41 ▲ 0.24% IRON ORE 161.91 — — COPPER 5.49 ▼ 2.49% GOLD 3,515 ▼ 4.62% SILVER 41.07 ▼ 7.33% SOY 1,221 ▲ 1.10% CORN 448.75 ▲ 2.22% WHEAT 592.00 ▲ 2.38% COFFEE 273.35 ▼ 3.08% SUGAR 17.07 ▼ 0.52% ORANGE JUICE 129.25 ▼ 2.49% COTTON 79.30 ▲ 4.41% COCOA 5,150 ▲ 1.72% BEEF 227.70 ▲ 2.18% CATTLE 335.43 ▼ 0.78% LITHIUM 51.98 ▼ 4.33% PETR4 42.67 — 0.00% VALE3 58.48 — 0.00% ITUB4 40.07 — 0.00% BBDC4 13.83 — 0.00% ABEV3 16.08 — 0.00% BBAS3 14.30 — 0.00% B3SA3 14.28 — 0.00% WEGE3 51.13 — 0.00% PRIO3 60.20 — 0.00% SUZB3 55.32 — 0.00% RENT3 28.86 — 0.00% AZZA3 14.63 — 0.00% CSAN3 3.08 — 0.00% RAIZ4 15.00 ▼ 10.71% PCAR3 3.23 — 0.00% GMAT3 4.18 ▲ 3.21% PSSA3 43.96 — 0.00% CVCB3 0.72 ▼ 7.69% POSI3 3.37 ▲ 6.31% SLCE3 17.53 — 0.00% NATU3 4.48 — 0.00% BRKM5 2.60 — 0.00% RANI3 8.01 ▼ 0.74%
since 2009
Sunday, November 22, 2026

The World Is Pulling Back on Cannabis. Brazil Just Doubled Down

By · · 2 min read

On January 28, Brazil’s health regulator Anvisa voted unanimously to let companies grow cannabis on Brazilian soil for the first time. The decision could reshape Latin America’s largest pharmaceutical market. This is part of The Rio Times’ daily coverage of Brazil affairs and Latin American financial news.

The problem: two of the world’s most respected medical journals just published evidence suggesting the product may not work the way millions believe.

The LatAm Brief

One email, every weekday morning. What moved in Latin American markets, politics and expat life.

Yesterday’s subject line: “Brazil's lower house takes up Lula's fiscal bill”

The World Is Pulling Back on Cannabis. Brazil Just Doubled Down
The World Is Pulling Back on Cannabis. Brazil Just Doubled Down
Key Points
— Brazil just approved domestic cannabis cultivation for medical use, unlocking a market nearing R$1 billion — while two major international studies say the science behind most cannabis therapies is weak or nonexistent.
— Nearly a third of medical cannabis users develop dependency, and high-potency products double the risk of heart disease, according to a review of 2,500 studies published in JAMA.
— Oregon, Amsterdam, and Thailand have all reversed cannabis liberalization in the past two years — raising the question of whether Brazil is arriving late to a party the world is already leaving.

The rules permit cultivation with up to 0.3% THC, allow cannabidiol in compounding pharmacies, and create a trial program for patient groups.

Free daily brief — no card needed
Get every Latest News story in one morning email
We build you a personalized brief around the topics you follow — free for 7 days. Love it? Your first month after that is US$1.

The sector hit R$971 ($183) million last year, 670,000 Brazilians use cannabis products, and over 660,000 import permits were filed in a decade. Advocates celebrated: domestic production means lower prices.

The World Is Pulling Back on Cannabis. Brazil Just Doubled Down

Then there is the science. A Cochrane review published this January — 21 trials, 2,100 patients — found no solid evidence cannabis relieves nerve pain better than placebo. A JAMA review of 2,500 studies went further: evidence is insufficient for chronic pain, anxiety, and insomnia.

Proven uses are narrow: chemotherapy nausea, HIV appetite loss, rare childhood epilepsy. The JAMA data also showed 29% of medical users developed dependency, 12.4% on high-potency products experienced psychotic symptoms, and daily inhalation doubled heart disease risk.

Psychiatrist Ronaldo Laranjeira of Unifesp called the regulation “a bizarrice” driven by industry lobbying. Cannabis prevalence surged from 3% to over 15% of Brazilians, and THC potency has risen from 1% to 20% over four decades in Canada. The Brazilian Psychiatric Association is blunt: “medical marijuana does not exist.”

What makes this globally significant is timing. Oregon recriminalized drugs in 2024 after overdose deaths spiked 1,500%. Amsterdam banned public cannabis smoking.

Thailand dismantled 11,000 dispensaries in 2025, three years after decriminalizing. Brazil is betting it can succeed where others stumbled. The answer depends on evidence the science has not delivered.

Related coverage: Brazil’s Morning Call | Brazil Bets Against Washington: Why Lula Rejected Trump’s Cr

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

RT
Ask Rio Times
17 years of Latin America reporting, on demand.
Open the full Ask Rio Times →

Read More from The Rio Times

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.